These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 382866)
21. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation. Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463 [TBL] [Abstract][Full Text] [Related]
22. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. Boraschi D; Meltzer MS J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721 [No Abstract] [Full Text] [Related]
23. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997 [TBL] [Abstract][Full Text] [Related]
24. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes. Nacy CA J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789 [TBL] [Abstract][Full Text] [Related]
25. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro]. Reisser D; Jeannin JF; Martin F C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063 [TBL] [Abstract][Full Text] [Related]
26. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages. Sone S; Fidler IJ J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635 [TBL] [Abstract][Full Text] [Related]
27. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG. Meltzer MS; Stevenson MM J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142 [No Abstract] [Full Text] [Related]
28. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages. Bout DT; Joseph M; David JR; Capron AR J Immunol; 1981 Jul; 127(1):1-5. PubMed ID: 7240738 [TBL] [Abstract][Full Text] [Related]
29. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets. Adams DO; Marino PA; Meltzer MS J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698 [TBL] [Abstract][Full Text] [Related]
30. Macrophage tumoricidal activity induced by human C-reactive protein. Zahedi K; Mortensen RF Cancer Res; 1986 Oct; 46(10):5077-83. PubMed ID: 3489521 [TBL] [Abstract][Full Text] [Related]
31. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate. Weinberg JB J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399 [TBL] [Abstract][Full Text] [Related]
32. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage. Varesio L J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571 [TBL] [Abstract][Full Text] [Related]
33. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages. Nacy CA; Leonard EJ; Meltzer MS J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333 [TBL] [Abstract][Full Text] [Related]
34. Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages. Okuno K; Hashimoto T; Qian JH; Tsuchida T; Fujiwara H; Hamaoka T Jpn J Clin Oncol; 1985 Mar; 15(1):87-94. PubMed ID: 3981817 [TBL] [Abstract][Full Text] [Related]
35. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens. James SL; Lazdins JK; Hieny S; Natovitz P J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456 [TBL] [Abstract][Full Text] [Related]
37. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin. Klostergaard J; Foster WA; Leroux ME J Biol Response Mod; 1987 Jun; 6(3):313-30. PubMed ID: 3298554 [TBL] [Abstract][Full Text] [Related]
38. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes. Nacy CA; Meltzer MS; Fortier AH J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291 [TBL] [Abstract][Full Text] [Related]
40. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents. Germain RN; Williams RM; Benacerraf B J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]